Joanne Chio on Innovation in Early Phase Trials
Add bookmark
Joanne Chio, Head of Clinical Trials at the Haematology- Oncology Research Group ( HORG), National University Cancer Institute, Singapore (NCIS), speaks to Andrea Charles from Pharma IQ about innovation in early phase trials. Chio also shares her insights on emerging trends in early phase clinical trials and strategies reduce clinical trial timelines and prevent failures.
[inlinead]
Have Your Say
Rate this feature and give us your feedback...
